Muscle-specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Cellular Signaling

Background:

• The mechanistic target of rapamycin (mTOR) pathway drives pathological cardiac remodeling through enhanced protein synthesis.
• While mTOR inhibition is protective, its specific role in translational control of cardiac gene networks in disease remains unclear.

Purpose of the Study:

• To elucidate the mTOR-dependent translational regulation of specific mRNA networks in the diseased heart.
• To identify novel therapeutic targets within the mTOR signaling pathway for cardiac remodeling.

Main Methods:

• Genome-wide sequencing in cardiomyocytes to analyze mTOR-dependent translational control.
• Investigation of the role of Cullin-associated NEDD8-dissociated protein 2 (Cand2) in cardiac remodeling.
• Mechanistic studies linking Cand2 to mTOR signaling and pathological cell growth.

Main Results:

• Identified Cand2 as a translationally upregulated gene dependent on mTOR activity in cardiomyocytes.
• Demonstrated that Cand2 deletion confers protection against pathological cardiac remodeling.
• Established that Cand2 promotes pathological cell growth by increasing Grk5 protein expression.

Conclusions:

• Cand2 is a key mediator linking mTOR signaling to pathological cardiac remodeling.
• Targeting Cand2 offers a potential therapeutic strategy for heart disease.
• Cell-type-specific modulation of mTOR signaling may hold therapeutic promise for cardiac conditions.